Evidence map›Paper›PMID 33450859›Full record

ArticleInternational journal of molecular sciences2021

Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation.

Bin Zhang, Ruenn Chai Lai, Wei Kian Sim, Andre Boon Hwa Choo, Ellen Birgit Lane, Sai Kiang Lim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 2 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Mesenchymal Stem Cells and Psoriasis: Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Anti-Psoriatic activity ofOpen veterinary journal · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations.Clinical, cosmetic and investigational dermatology · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bin ZhangInstitute of Molecular and Cell Biology (IMCB)-A*STAR, 8A Biomedical Grove, #05-39 Immunos, Singapore 138648, Singapore.
Ruenn Chai LaiInstitute of Molecular and Cell Biology (IMCB)-A*STAR, 8A Biomedical Grove, #05-39 Immunos, Singapore 138648, Singapore.
Wei Kian SimInstitute of Molecular and Cell Biology (IMCB)-A*STAR, 8A Biomedical Grove, #05-39 Immunos, Singapore 138648, Singapore.
Andre Boon Hwa ChooBioprocessing Technology Institute (BTI)-A*STAR, 20 Biopolis Way, Singapore 138668, Singapore.
Ellen Birgit LaneSkin Research Institute of Singapore (SRIS)-A*STAR, 8A Biomedical Grove, #06-06 Immunos, Singapore 138648, Singapore.
Sai Kiang LimInstitute of Molecular and Cell Biology (IMCB)-A*STAR, 8A Biomedical Grove, #05-39 Immunos, Singapore 138648, Singapore.
Agency for Science, Technology and Research · SG

Funding

Agency of Science, Technology & Research (A*STAR) I1801E0019
6 · The paper itself

Abstract

Severe psoriasis, a chronic inflammatory skin disease is increasingly being effectively managed by targeted immunotherapy but long-term immunotherapy poses health risk and loss of response. Therefore, there is a need for alternative therapy strategies. Mesenchymal stem/stromal cell (MSC) exosomes are widely known for their potent immunomodulatory properties. Here we investigated if topically applied MSC exosomes could alleviate psoriasis-associated inflammation. Topically applied fluorescent exosomes on human skin explants were confined primarily to the stratum corneum with <1% input fluorescence exiting the explant over a 24-h period. Nevertheless, topically applied MSC exosomes in a mouse model of imiquimod (IMQ) psoriasis significantly reduced IL-17 and terminal complement activation complex C5b-9 in the mouse skin. MSC exosomes were previously shown to inhibit complement activation, specifically C5b-9 complex formation through CD59. Infiltration of neutrophils into the stratum corneum is characteristic of psoriasis and neutrophils are a major cellular source of IL-17 in psoriasis through the release of neutrophil extracellular traps (NETs). We propose that topically applied MSC exosomes inhibit complement activation in the stratum corneum and this alleviates IL-17 release by NETS from neutrophils that accumulate in and beneath the stratum corneum.

Indexed as

Administration, TopicalAnimalsBiomarkersBiopsyDisease Models, AnimalExosomesImiquimodMesenchymal Stem CellsMicePermeabilityPhenotypePsoriasisSkinSkin AbsorptionBiomarkersImiquimodexosomemesenchymal stem cellpsoriasis

Identifiers

PMID33450859
PMCPMC7828312
OpenAlexW3118895525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.